CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
Meijie Tian(National Institutes of Health), Javed Khan(Kent State University), Michael C. Kelly(National Cancer Institute), Jun S. Wei(Center for Cancer Research), Zhongmei Zhang(National Cancer Institute), Jerry T. Wu(National Cancer Institute), Abdelrahman Rahmy(National Institutes of Health), David Milewski(National Cancer Institute), Hsien-Chao Chou(National Cancer Institute), Adam Cheuk(National Institutes of Health), Can Liu(University of Maryland, College Park), Eleanor G. Pope(National Institutes of Health), Xinyu Wen(National Institutes of Health), S. Badr(Center for Cancer Research), Yong Kim(National Institutes of Health)
Cited by 26
Related Papers
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k
Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
|Cancer Discovery|2014|789
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563